Home > News

News

Glaxo Wellcome UK Ltd v. Sandoz Ltd [2017] EWCA Civ 33510 May 2017This appeal is in a large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to respiratory inhalers. The UK action forms part of a series of international disputes concerning these pharmaceutical products. Glaxo owns an EU colour per se trade mark which is visually represented by a […]
Charlotte May speaks at the launch of the London Chapter of ChIPs hosted at the Supreme Court S4 May 2017Charlotte May QC was one of the panellists at the launch of the London Chapter of ChIPs hosted at the Supreme Court on Thursday 27 April. ChIPs is a non-profit organisation dedicated to advancing women in technology, law and policy. The launch of the London Chapter represents an important step in helping to realise the […]
(1) Sandoz Ltd (2) Hexal AG v (1) G.D. Searle LLC (2) Janssen Sciences Ireland UC [2017] EWHC 987 (Pat)3 May 2017Charlotte May QC and William Duncan represented the claimants in an action concerning the defendants’ supplementary protection certificate (SPC) for the drug darunavir (marketed as “Prezista”). The case raised a question about the correct application of article 3(a) of Regulation 469/2009/EC (the “SPC Regulation”) – which states that a product the subject of an SPC […]
Glaxo Wellcome UK Limited (T/A Allen & Hanburys), Glaxo Group Limited v Sandoz Limited, Sandoz International GMBH [2017] EWCA Civ 2276 April 2017Martin Howe QC and Iona Berkeley represented the Respondents, “Sandoz”, in Glaxo’s Appeal against the decision of HHJ Hacon refusing permission to join two additional defendants to its claim for passing off. Glaxo alleged passing off on the basis that Sandoz had marketed asthma inhalers similar to Glaxo’s ‘Seratide’ inhalers in the UK. Glaxo had […]
Varian Medical Systems International AG vs (1) Elekta Ltd, (2) Elekta Holdings Ltd [2017] EWHC 712 (Pat).6 April 2017James Abrahams QC and James Whyte successfully represented the Defendants (“Elekta”) in Varian’s claim for infringement of its patent for a combined MRI and radiotherapy device. Elekta denied that its combined MRI and radiotherapy machine infringed the Patent, and further claimed that the Patent was invalid for insufficiency, obviousness and added matter. The judge held […]